Goodwin represented Pieris Pharmaceuticals in its strategic collaboration with AstraZeneca to develop novel inhaled drugs that leverage Pieris’ Anticalin® platform. AstraZeneca will make an upfront and […]
Pieris Pharmaceuticals and AstraZeneca Strike up to $2.1 Billion Collaboration on Anticalin-based Inhaled Treatments for Respiratory Diseases
Sabra Health Care and Care Capital Properties to Combine in US$7.4 Billion Transaction
UBS Investment Bank is acting as financial advisor to Sabra and O’Melveny & Myers LLP and Fried, Frank, Harris, Shriver & Jacobson LLP are acting as […]
Coach’s $2.4 Billion Acquisition of Kate Spade
Paul, Weiss is representing high-end handbag and apparel maker Kate Spade & Company in its acquisition by Coach, Inc., a leading New York luxury accessories company. […]
Lundin Mining’s $1.136 Billion Sale of Interest in Tenke Copper Project
Paul, Weiss represented Lundin Mining Corporation in the sale of its indirect interest in the Tenke copper project in the Democratic Republic of Congo to an […]
Virtu Financial’s $1.4 Billion Acquisition of KCG Holdings
Paul, Weiss is representing high-speed trading firm Virtu Financial, Inc. in its approximately $1.4 billion all-cash acquisition of retail electronic trading firm KCG Holdings, Inc. Virtu […]
Chequers Capital XVII Fund’s €1.1 Billion Fund Raising
A Goodwin cross-border team advised Chequers Capital on the closing of its XVII Fund with a total commitment of €1.1 billion raised in less than three […]
Sawai Pharmaceutical’s $1.05 Billion Acquisition of the Generics Business of Upsher-Smith Laboratories
Debevoise & Plimpton LLP is advising Sawai Pharmaceutical Co. Ltd., a leading Japanese generic pharmaceuticals manufacturer, in its $1.05 billion acquisition of the generic pharmaceuticals business […]
Akorn’s $4.3 Billion Acquisition by Fresenius Kabi
Cravath is representing Akorn in connection with the transaction. On April 24, 2017, Akorn and Fresenius Kabi announced that Fresenius Kabi has agreed to acquire Akorn, […]
Becton Dickinson and Company’s $24 Billion Acquisition of C.R. Bard
Perella Weinberg Partners LP is acting as lead financial advisor to BD. Citi is also serving as a financial advisor to BD and will be providing […]
UCP’s $1.3 Billion Merger withCentury Communities
Paul, Weiss is representing real estate developer UCP, Inc., a subsidiary of PICO Holdings, Inc., in its stock and cash merger with homebuilder Century Communities, Inc. […]
Sawai Pharmaceutical Co. Ltd.’s $1.05 billion acquisition of Upsher?Smith Laboratories, Inc.
Sawai Pharmaceutical Co. Ltd. has signed an agreement to acquire the generic pharmaceuticals business of Upsher?Smith Laboratories, Inc., from its parent, ACOVA Inc. Upsher-Smith is a […]
Cardinal Health to Acquire a $6.1 Billion Leading Patient Product Portfolio from Medtronic
Goldman, Sachs & Co. and Perella Weinberg Partners LP served as Cardinal Health’s financial advisors on this transaction, and Skadden, Arps, Slate, Meagher & Flom LLP […]